IL9 and Alzheimer disease: We found that cimifugin administered only in the initial stage attenuated thickening of the epidermis, reduced infiltration of inflammatory cells and decreased Th2 cytokines IL‐4, IL‐5, IL‐9, IL‐13 in the ear of the AD model.